Patents by Inventor Arie S. Belldegrum

Arie S. Belldegrum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for treating cancer
    Patent number: 8822438
    Abstract: Methods and compositions for treating cancer are described herein. More particularly, the methods for treating cancer comprise administering a 17?-hydroxylase/C17,20-lyase inhibitor, such as abiraterone acetate (i.e., 3?-acetoxy-17-(3-pyridyl)androsta-5,16-diene), in combination with at least one additional therapeutic agent such as an anti-cancer agent or a steroid. Furthermore, disclosed are compositions comprising a 17?-hydroxylase/C17,20-lyase inhibitor, and at least one additional therapeutic agent, such as an anti-cancer agent or a steroid.
    Type: Grant
    Filed: February 24, 2011
    Date of Patent: September 2, 2014
    Assignee: Janssen Oncology, Inc.
    Inventors: Alan H. Auerbach, Arie S. Belldegrum
  • Methods and Compositions for Treating Cancer
    Publication number: 20110144016
    Abstract: Methods and compositions for treating cancer are described herein. More particularly, the methods for treating cancer comprise administering a 17?-hydroxylase/C17,20-lyase inhibitor, such as abiraterone acetate (i.e., 3?-acetoxy-17-(3-pyridyl) androsta-5,16-diene), in combination with at least one additional therapeutic agent such as an anti-cancer agent or a steroid. Furthermore, disclosed are compositions comprising a 17?-hydroxylase/C17,20-lyase inhibitor, and at least one additional therapeutic agent, such as an anti-cancer agent or a steroid.
    Type: Application
    Filed: February 24, 2011
    Publication date: June 16, 2011
    Inventors: Alan H. Auerbach, Arie S. Belldegrum